Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PROTAGONIST THERAPEUTICS, INC.

(PTGX)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
8.070 USD   +3.46%
12/01Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit
PR
11/16Protagonist Therapeutics Reports Granting of Inducement Award
PR
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintains Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on PROTAGONIST THERAPEUTICS, INC.
11/10HC Wainwright Lowers Price Target on Protagonist Therapeutics to $33 From $50, Maintain..
MT
08/25JMP Securities Reinstates Protagonist Therapeutics at Market Outperform With $21 Price ..
MT
05/18Piper Sandler Adjusts Price Target on Protagonist Therapeutics to $35 From $60, Reitera..
MT
05/05SVB Leerink Adjusts Protagonist Therapeutics' Price Target to $30 from $50, Keeps Outpe..
MT
02/11BTIG Initiates Protagonist Therapeutics at Buy With $55 Price Target
MT
2021JMP Securities Adjusts Price Target on Protagonist Therapeutics to $70 From $60, Keeps ..
MT
2021Protagonist Therapeutics : JMP Securities Adjusts Price Target ..
MT
2021Protagonist Therapeutics : JMP Securities Adjusts Price Target ..
MT
2021Protagonist Therapeutics : SVB Leerink Adjusts Protagonist Ther..
MT
2021Protagonist Therapeutics : JPMorgan Upgrades Protagonist Therap..
MT
2021Analyst recommendations: Cigna, Halliburton, Nike, Nio, Trex...
MS
2021Protagonist Therapeutics : Northland Capital Markets Upgrades P..
MT
2021Protagonist Therapeutics : JMP Securities Adjusts Price Target ..
MT
2021Protagonist Therapeutics : SVB Leerink Adjusts Protagonist Ther..
MT
2021Protagonist Therapeutics : HC Wainwright Adjusts Protagonist Th..
MT
2021Protagonist Therapeutics : JPMorgan Downgrades Protagonist Ther..
MT
2021Protagonist Therapeutics : Northland Capital Downgrades Protago..
MT
2021Protagonist Therapeutics : HC Wainwright Adjusts Protagonist Th..
MT
2021Protagonist Therapeutics : SVB Leerink Adjusts Protagonist Ther..
MT
2021Protagonist Therapeutics : Piper Sandler Adjusts Protagonist Th..
MT
2021Protagonist Therapeutics : HC Wainwright Adjusts Protagonist Th..
MT
2021Protagonist Therapeutics : Northland Adjusts Price Target on Pr..
MT
2021Protagonist Therapeutics : Northland Capital Markets Initiates ..
MT
2021Protagonist Therapeutics : JMP Securities Initiates Protagonist..
MT
2021Protagonist Therapeutics : HC Wainwright Adjusts Price Target o..
MT
2021Protagonist Therapeutics : SVB Leerink Adjusts Protagonist Ther..
MT
2021Protagonist Therapeutics : JP Morgan Starts Protagonist Therape..
MT
2020Protagonist Therapeutics : Piper Sandler Starts Protagonist The..
MT
2020Protagonist Therapeutics : BMO Capital Adjusts Protagonist Ther..
MT
Upcoming event on PROTAGONIST THERAPEUTICS, INC.